Q/C Technologies, Inc. Royalty Expense
Q/C Technologies, Inc. (QCLS) reported Royalty Expense of $86.52 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2020-03-25
- Q/C Technologies, Inc. royalty expense for the quarter ending 2019-12-31 was $9.81K, a 45.99% decline year-over-year.
- Q/C Technologies, Inc. royalty expense for the quarter ending 2019-09-30 was $21.90K.
- Q/C Technologies, Inc. royalty expense for the quarter ending 2019-06-30 was $23.25K, a 14.15% decline year-over-year.
- Q/C Technologies, Inc. royalty expense for the quarter ending 2019-03-31 was $31.28K, a 1.28% decline year-over-year.
- Q/C Technologies, Inc. royalty expense for fiscal 2019 was $86.52K, a 45.21% increase from fiscal 2018.
- Q/C Technologies, Inc. royalty expense for fiscal 2018 was $59.58K, a 70.52% decline from fiscal 2017.
- Q/C Technologies, Inc. royalty expense for fiscal 2017 was $202.13K, a 31.38% increase from fiscal 2016.
- Q/C Technologies, Inc. royalty expense for fiscal 2016 was $153.85K.
| Period end | Royalty Expense 3 month | Royalty Expense 3 month as first filed | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $9.81K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $31.71K derived: sum of 2 quarters · filed 2020-03-25 | $54.97K derived: sum of 3 quarters · filed 2020-03-25 | $86.52K 10-K · filed 2020-03-25 | |
| 2019-09-30 | $21.90K 10-Q · filed 2019-11-14 | $45.15K derived: sum of 2 quarters · filed 2019-11-14 | $76.71K 10-Q · filed 2019-11-14 | $94.60K derived: sum of 4 quarters · filed 2020-03-25 | |
| 2019-06-30 | $23.25K 10-Q · filed 2019-08-14 | $54.80K 10-Q · filed 2019-08-14 | $72.70K derived: sum of 3 quarters · filed 2020-03-25 | $55.35K derived: sum of 4 quarters · filed 2020-03-25 | |
| 2019-03-31 | $31.28K 10-Q · filed 2019-05-20 | $49.45K derived: sum of 2 quarters · filed 2020-03-25 | $32.10K derived: sum of 3 quarters · filed 2020-03-25 | $59.18K derived: sum of 4 quarters · filed 2020-03-25 | |
| 2018-12-31 | $18.17K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $813.00 derived: sum of 2 quarters · filed 2020-03-25 | $27.89K derived: sum of 3 quarters · filed 2020-03-25 | $59.58K 10-K · filed 2020-03-25 | |
| 2018-09-30 | -$17.35K 10-Q · filed 2018-11-14 | $9.73K derived: sum of 2 quarters · filed 2019-08-14 | $41.42K 10-Q · filed 2019-11-14 | $115.44K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-06-30 | $27.08K 10-Q · filed 2019-08-14 | $58.77K 10-Q · filed 2019-08-14 | $132.79K derived: sum of 3 quarters · filed 2019-08-14 | $167.12K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $31.69K 10-Q · filed 2019-05-20 | $105.71K derived: sum of 2 quarters · filed 2019-05-20 | $140.03K derived: sum of 3 quarters · filed 2019-05-20 | $201.54K derived: sum of 4 quarters · filed 2019-05-20 | |
| 2017-12-31 | $74.02K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $108.35K derived: sum of 2 quarters · filed 2019-04-01 | $169.85K derived: sum of 3 quarters · filed 2019-04-01 | $202.13K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $34.33K 10-Q · filed 2018-11-14 | $61.50K 10-Q · filed 2017-11-14 | $95.83K derived: sum of 2 quarters · filed 2018-11-14 | $128.11K 10-Q · filed 2018-11-14 | $164.01K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $61.50K 10-Q · filed 2018-08-14 | $93.78K 10-Q · filed 2018-08-14 | $129.69K derived: sum of 3 quarters · filed 2018-08-14 | $257.79K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $32.28K 10-Q/A · filed 2018-07-13 | $68.18K derived: sum of 2 quarters · filed 2018-07-13 | $196.29K derived: sum of 3 quarters · filed 2018-07-13 | $290.07K derived: sum of 4 quarters · filed 2018-07-13 | |
| 2016-12-31 | $35.91K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-07-13 | $164.01K derived: sum of 2 quarters · filed 2018-07-13 | $257.79K derived: sum of 3 quarters · filed 2018-07-13 | $153.85K 10-K/A · filed 2018-07-13 | |
| 2016-09-30 | $128.11K 10-Q/A · filed 2018-07-13 | $221.89K derived: sum of 2 quarters · filed 2018-07-13 | $117.95K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $93.78K 10-Q/A · filed 2018-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |